| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09587429 |
| PharmacoGx | BRD-K09587429 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-13 |
| mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-14 |
| mRNA | AFM | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-20 |
| mRNA | TMEM207 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-21 |
| mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.36 | 6e-19 |
| mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-22 |
| mRNA | SLC35D3 | CTRPv2 | pan-cancer | AAC | 0.39 | 8e-25 |
| mRNA | RALYL | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-26 |
| mRNA | IMPG1 | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-26 |
| mRNA | WEE2 | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-28 |
